SOUTH SAN FRANCISCO, Calif., AND WASHINGTON, May 18, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) and The ALS Association today announced the continuation of their partnership in the fight against ALS. Cytokinetics is a sponsor of the 2022 ALS Roundtables, the National Advocacy Conference and the ALS Focus survey program. Cytokinetics is also a Platinum Level Sponsor for initiatives led by The ALS Association Golden West Chapter for people with ALS in the Bay Area.
Cytokinetics and the ALS Association Renew Partnership to Advance the Fight Against ALS
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.
